TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
GKOS

Glaukos Corp

Healthcare · Medical Devices

154.40$ -0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Glaukos Corp (GKOS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 186 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GKOS
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
30 33 36 41 40 42 40 43 44 54 54 59 59 66 55 32 65 73 68 78 75 73 68 73 71 71 74 80 78 82 86 96 97 105 107 124 134 143 151 186 613
3.9 4.8 5.2 5.5 5.7 4.6 5.8 6.2 6.0 7.1 7.1 7.9 7.7 16 33 22 18 20 17 18 15 17 17 18 17 17 18 20 19 19 20 23 23 29 24 27 29 32 33 34 128
26 28 31 36 35 37 34 37 38 47 47 51 51 50 23 9.9 47 54 51 60 59 56 51 55 54 54 56 60 60 63 65 73 74 77 82 97 105 111 117 152 485
7.8 7.4 8.9 9.6 9.8 11 11 13 13 13 14 17 17 20 25 19 20 21 21 24 29 27 27 32 29 36 35 33 33 37 31 34 35 37 32 37 38 44 44 51 177
17 19 21 25 24 24 27 29 32 30 35 38 44 117 51 38 39 42 44 45 44 46 44 50 47 49 54 53 54 60 62 66 64 69 71 83 83 95 93 116 387
25 28 30 40 34 36 38 41 45 45 49 57 63 80 75 57 59 65 63 75 48 74 41 92 76 88 89 89 88 102 104 103 99 106 103 120 121 138 137 169 565
1.0 0.5 0.3 -3.9 0.7 0.5 -3.7 -4.2 -6.9 1.9 -1.9 -6.2 -12 -30 -53 -47 -12 -11 -12 -14 11 -18 9.8 -37 -22 -34 -33 -29 -28 -39 -39 -30 -25 -29 -21 -23 -16 -27 -20 -17 -80
0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.6 1.0 0.0 0.1 1.0 1.0 0.5 0.9 1.9 5.7 5.6 3.2 3.3 3.4 3.4 3.4 3.4 3.5 3.4 3.4 3.4 3.4 3.4 3.5 3.4 1.7 1.6 1.2 1.2 1.2 1.1 1.1 1.5 4.9
1.3 0.0 0.9 -3.3 1.4 1.0 -2.7 -5.4 -6.6 2.3 -1.2 -6.2 -13 -29 -55 -47 -17 -14 -16 -17 6.4 -22 5.7 -46 -27 -31 -34 -32 -30 -37 -40 -50 -21 -34 -18 -19 -16 -140 -19 -18 -193
0.1 -0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.2 -66 -0.5 -7.4 -0.9 -3.2 0.3 0.2 0.2 -0.4 0.3 -0.1 0.2 0.3 0.4 0.4 0.0 0.1 0.4 0.3 0.2 -0.1 0.3 0.2 0.2 -6.2 0.5 0.7 -4.8
1.2 0.1 0.9 -3.3 1.3 1.0 -2.7 -5.4 -6.6 1.8 -1.3 -6.3 -14 37 -54 -40 -16 -11 -16 -17 6.2 -22 5.4 -46 -28 -31 -35 -33 -30 -37 -41 -51 -21 -34 -18 -20 -16 -134 -20 -18 -188
2.5 1.7 1.9 2.9 2.3 2.5 -2.0 -3.7 -4.9 3.1 0.0 -3.3 -10 -24 -45 -37 -2.3 0.5 -4.4 -5.5 18 -10 18 -36 -13 -19 -21 -22 -15 -24 -27 -37 -9.5 -22 -7.4 -8.6 -4.6 -125 -5.3 -6.9 -142

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?